Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13126
PUT
Lexicon Pharmaceuticals
LXRX
$894M
| $43K | ﹤0.01% |
17,900
-21,800
| -55% | -$42.5K |
|
13127
reAlpha
AIRE
$9.19M
| $42.9K | ﹤0.01% |
+22,210
| New | +$80.9K |
|
13128
Treasure Global
TGL
$5.86M
| $42.8K | ﹤0.01% |
+10,968
| New | +$45.7K |
|
|
BDN
13129
CALL
Brandywine Realty Trust
BDN
$499M
| $42.8K | ﹤0.01% |
13,500
+1,200
| +10% | +$3.61K |
|
13130
PUT
Compugen
CGEN
$228M
| $42.6K | ﹤0.01% |
+19,900
| New | +$49.9K |
|
|
JZ
13131
Jianzhi Education Technology Group
JZ
$1.69M
| $42.5K | ﹤0.01% |
+9,535
| New | +$196K |
|
|
DGNX
13132
PUT
Diginex Ltd
DGNX
$40.8M
| $42.5K | ﹤0.01% |
28,688
+17,863
| +165% | +$36.9K |
|
|
SMTK
13133
SmartKem
SMTK
$1.38M
| $42.4K | ﹤0.01% |
3,461
+3,014
| +674% | +$44.9K |
|
13134
Fuel Tech
FTEK
$59.6M
| $42.1K | ﹤0.01% |
19,070
-202,329
| -91% | -$300K |
|
13135
PUT
BRC Inc
BRCC
$130M
| $42.1K | ﹤0.01% |
3,790
+1,130
| +42% | +$14K |
|
|
CMRC
13136
PUT
Commerce.com Inc Series 1
CMRC
$297M
| $42K | ﹤0.01% |
14,200
-5,500
| -28% | -$15.8K |
|
13137
Investcorp Credit Management BDC
ICMB
$12.4M
| $42K | ﹤0.01% |
+35,918
| New | +$53.5K |
|
13138
Energy Focus
EFOI
$17.2M
| $41.9K | ﹤0.01% |
+12,705
| New | +$44K |
|
|
NVX
13139
CALL
NOVONIX
NVX
$76.1M
| $41.8K | ﹤0.01% |
9,090
-8,210
| -47% | -$54.6K |
|
13140
Cardio Diagnostics
CDIO
$5.92M
| $41.8K | ﹤0.01% |
+19,071
| New | +$36.1K |
|
13141
Mustang Bio
MBIO
$3.82M
| $41.7K | ﹤0.01% |
59,459
+6,259
| +12% | +$4.45K |
|
13142
PUT
Castor Maritime
CTRM
$22M
| $41.6K | ﹤0.01% |
+19,900
| New | +$39.6K |
|
13143
CALL
Oxford Square Capital
OXSQ
$142M
| $41.4K | ﹤0.01% |
+31,400
| New | +$50.3K |
|
|
PVL
13144
Permianville Royalty Trust
PVL
$62M
| $41.4K | ﹤0.01% |
+24,489
| New | +$45.6K |
|
13145
CALL
Mercer International
MERC
$25.9M
| $41.4K | ﹤0.01% |
+62,700
| New | +$62.4K |
|
|
NCNA
13146
NuCana
NCNA
$5.41M
| $41.2K | ﹤0.01% |
27,099
+13,244
| +96% | +$26.5K |
|
13147
Processa Pharmaceuticals
PCSA
$5.47M
| $40.9K | ﹤0.01% |
+21,306
| New | +$55.2K |
|
|
TII
13148
PUT
Titan Mining Corp
TII
$279M
| $40.7K | ﹤0.01% |
+18,600
| New | +$46.3K |
|
|
HUYA
13149
PUT
Huya Inc
HUYA
$473M
| $40.7K | ﹤0.01% |
17,700
+7,400
| +72% | +$21K |
|
|
DCX
13150
Digital Currency X Technology Inc
DCX
$123M
| $40.7K | ﹤0.01% |
+37,657
| New | +$81.2K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.